Ballance David James 4
4 · PhaseBio Pharmaceuticals Inc · Filed Mar 1, 2019
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-27+45,000→ 45,000 totalExercise: $3.15Exp: 2029-02-27→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 27, 2019, subject to the reporting person's continued service through each such date.